COVID Vaccine or Gene Therapy?
Strictly speaking, the vaccines against SARS-CoV-2 are not technically vaccines at all.
They are all examples of gene therapy, even if all of the products do not directly alter the DNA.
According to the FDA:
Human gene therapy seeks to modify or manipulate the expression of a gene or to alter the biological properties of living cells for therapeutic use.
According to that definition, a gene therapy does not have to alter the gene in order to be classified as gene therapy.
Prior to this year, all messenger RNA therapies have been classified as gene therapies by both the FDA and the European Union.
Moderna Vaccine Description (from here)
The nucleoside-modified mRNA in the Moderna COVID‑19 Vaccine is formulated in lipid particles, which enable delivery of the nucleoside‑modified mRNA into host cells to allow expression of the SARS‑CoV‑2 Spike antigen. The vaccine elicits an immune response to the Spike antigen, which protects against COVID‑19.
Pfizer Vaccine Description (from here and here)
The Pfizer BioNTech COVID-19 vaccine is a messenger RNA (mRNA) vaccine that has both synthetic, or chemically produced, components and enzymatically produced components from naturally occurring substances such as proteins.
The Pfizer-BioNTech COVID-19 Vaccine is an unapproved vaccine that may prevent COVID-19. There is no FDA-approved vaccine to prevent COVID-19.
The Pfizer-BioNTech COVID-19 Vaccine includes the following ingredients: mRNA, lipids ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate), 2 [(polyethylene glycol)-2000]-N,N-ditetradecylacetamide, 1,2-Distearoyl-sn-glycero-3- phosphocholine, and cholesterol), potassium chloride, monobasic potassium phosphate, sodium chloride, dibasic sodium phosphate dihydrate, and sucrose.
Johnson & Johnson Vaccine Description (from here)
Janssen is a human adenovirus viral vector COVID-19 vaccine. Janssen’s AdVac® vectors are based on a specific type of adenovirus. This type of adenovirus has been genetically modified so that it can no longer multiply in humans and cannot cause disease. The modified adenovirus is used as a vector (a carrier) of the genetic code of an antigen. Antigens are substances foreign to the human body that trigger an immune response.
AstraZeneca Vaccine Description
The Oxford–AstraZeneca COVID-19 vaccine is a replication-deficient chimpanzee adenovirus vector, containing the full‐length codon‐optimised coding sequence of SARS-CoV-2 spike protein along with a tissue plasminogen activator (tPA) leader sequence.
The adenovirus is called replication-deficient because some of its essential genes were deleted and replaced by a gene coding for the spike protein. Following vaccination, the adenovirus vector enters the cells, releases its genes, those are transported to the cell nucleus, thereafter the cell’s machinery does the transcription into mRNA and the translation into proteins.
**AstraZeneca is the only vaccine in this group that did not have a saline placebo in the clinical trials.
Could COVID Vaccines Integrate Into Host DNA?
Each of the vaccines do have the ability to integrate into the host DNA for the mere fact that human cells can contain an enzyme called reverse transcriptase, which is considered to be endogenous to humans.
This is not a conspiracy theory:
Eight percent of our DNA consists of remnants of ancient viruses, and another 40 percent is made up of repetitive strings of genetic letters that is also thought to have a viral origin. (source here)
Apart from retroviruses, the genome of other RNA viruses has been recently identified in the host genome. However, in these cases, integration seems to have occurred incidentally. (source here)
Reverse transcription is one working hypothesis for why some people appear to be “reinfected” with COVID many times— that this may be an example of the corona virus integrating into host DNA, which is what viruses do sometimes, and this is part of evolution.
It’s important to remember that some of these vaccines differ from traditional vaccines in that the injections (in the case of the mRNA vaccines) are not eliciting an antibody response as its primary mechanism, they are using your cells to create the antigen, which is fundamentally very different from traditional vaccine technology.
Guest post by Johnathan S.:
What Is Gene Therapy?
According to the FDA:
Human gene therapy seeks to modify or manipulate the expression of a gene or to alter the biological properties of living cells for therapeutic use.
According to that definition, a gene therapy does not have to alter the gene in order to be classified as gene therapy.
Prior to this year, all mRNA therapies have been classified as gene therapies.
- Pfizer and Moderna are genetic engineering, but do NOT enter the cell nucleus (unless an enzyme is present, called reverse transcriptase, in that case it *could* enter the cell nucleus).
- AstraZeneca‘s product DOES enter the nucleus, which makes it genetic engineering by gene therapy.
According to the New York Times:
The mRNA vaccines (Moderna & Pfizer) are a form of “cellular engineering”: They take a snip of the Sars-COV-2 virus (the part with instructions which make the “spike” protein), inject it into the body, expect body cells to take those instructions and expect the ribosomes to produce the “spikes”, which will then hopefully migrate to the cell’s outer membrane, where the immune system will react to it.
Problems Associated with the Covid Vaccine “Therapies”:
1. Out of 29 viral proteins, they picked one: the “spike” protein.
The reason they picked this one protein, is because they THINK using the nuclear protein is what caused disease to worsen (via ADE (antibody dependent enhancement) with Dengue vaccine.
SARS-CoV-2 contains four major structural proteins, namely spike (S), membrane (M) and envelope (E) proteins, all of which are embedded in the viral surface envelope, and nucleocapsid protein, which is in the ribonucleoprotein core1, 45 (Fig. 1).
- S proteins are responsible for recognition of the host cellular receptor to initiate virus entry.
- M proteins are embedded in the envelope and shape the virion envelope.
- E proteins are small polypeptides that are crucial for CoV infectivity.
- N proteins make up the helical nucleocapsid and bind along the viral RNA genome.
In addition to these structural proteins, SARS-CoV-2 encodes 16 non-structural proteins (nsp1–16) and 9 accessory proteins. Several of these viral proteins could potentially serve as targets of vaccine-induced immune responses.
2. The “spike” mutates.
Therefore, you will need constant boosters, to be protected against future variants, similar to influenza vaccines.
“Some of the mutations it carries, including ones named E484K and K417N, change its surface protein, spike, and have been shown in the lab to reduce how well monoclonal antibodies combat the virus.”
3. The LNP (lipid nano-particles) which coat the mRNA snips has issues:
From Moderna S-1, page 33:
“Most of our investigational medicines are formulated and administered in an LNP which may lead to systemic side effects related to the components of the LNP which may not have ever been tested in humans. While we have continued to optimize our LNPs, there can be no assurance that our LNPs will not have undesired effects.
Our LNPs could contribute, in whole or in part, to one or more of the following: immune reactions, infusion reactions, complement reactions, opsonation reactions, antibody reactions including IgA, IgM, IgE or IgG or some combination thereof, or reactions to the PEG from some lipids or PEG otherwise associated with the LNP.
Certain aspects of our investigational medicines may induce immune reactions from either the mRNA or the lipid as well as adverse reactions within liver pathways or degradation of the mRNA or the LNP, any of which could lead to significant adverse events in one or more of our clinical trials.
Many of these types of side effects have been seen for legacy LNPs. There may be resulting uncertainty as to the underlying cause of any such adverse event, which would make it difficult to accurately predict side effects in future clinical trials and would result in significant delays in our programs.”
Additionally, a 2018 study titled Lipid Nanoparticles: A Novel Approach for Brain Targeting states:
“…lipid nanoparticles are taken up readily by the brain because of their lipophilic nature. The bioacceptable and biodegradable nature of lipid nanoparticles makes them less toxic and suited for brain targeting.” The article also states, “these nanostructures need to be investigated intensively to successfully reach the clinical trials stage.”
Read the letter to Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research by the Informed Consent Action Network (ICAN) here.
4. The PEG (polyethylene glycol), which protects the mRNA snips, also has issues.
According to Mercola.com:
Many suspect the PEG found in both Pfizer’s and Moderna’s vaccines might be the culprit causing allergic reactions and anaphylaxis. PEG has never been used in an approved vaccine, but is used in certain drugs known to cause anaphylaxis.27 According to Robert F. Kennedy Jr., “studies show that 1 in 7 Americans28 may unknowingly be at risk of experiencing an allergic reaction to PEG.”
He believes “everyone should be screened for anti-PEG antibodies before getting the Pfizer and Moderna vaccines,” adding that “It is unconscionable that, instead, the FDA and CDC are encouraging people to go ahead and risk a life-threatening anaphylactic reaction and just assume that someone will be on hand to save them.”
Read more about LPNs and PEG here.
5. Prior COVID Infection Increases Risk For Adverse Reactions
Anyone who has COVID (whether they have symptoms or not), or has recently (within 6 months) had it, may still have inflamed blood vessels — and the spikes may aggravate that condition, causing blockage (which results in strokes or heart attacks). This may explain the extreme reactions in some people post vaccination.
6. There is Some Evidence that Sars-Cov-2 May Replicate in Bacteria Cells–And Then What?
The Sars-COV-2 may be a bacteriophage (a virus which attacks & reproduces within bacteria), which the vaccine (and therefore the immune system) may not be able to stop.
Dr. Sherri Tenpenny Explains mRNA ‘Vaccines’
Watch this video of Dr. Sherri Tenpenny explaining how the new COVID-19 mRNA therapies work.
